Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction

Giancarlo Marenzi1, Gianfranco Lauri, Emilio Assanelli

  • 1Centro Cardiologico Monzino, I.R.C.C.S., Institute of Cardiology of the University of Milan, Milan, Italy. giancarlo.marenzi@ccfm.it

Insights

Contrast-induced nephropathy (CIN) affects 19% of patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). CIN significantly increases hospital stay and mortality, highlighting the need for preventive strategies in high-risk individuals.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • Contrast-induced nephropathy (CIN) is a known complication following percutaneous coronary intervention (PCI).
  • Patients with acute myocardial infarction (AMI) undergoing primary PCI are at increased risk due to potential hemodynamic instability and challenges with prophylactic measures.

Purpose of the Study:

  • To determine the incidence of CIN after primary PCI in AMI patients.
  • To identify clinical predictors associated with CIN development.
  • To evaluate the outcomes of patients who develop CIN post-primary PCI.

Main Methods:

  • Serum creatinine levels were monitored daily for three days in 208 consecutive AMI patients undergoing primary PCI.
  • CIN was defined as an increase in serum creatinine concentration greater than 0.5 mg/dl.
  • Multivariate analysis was used to identify independent predictors of CIN.

Main Results:

  • The overall incidence of CIN was 19% (40 patients).
  • Patients with baseline creatinine clearance <60 ml/min had a significantly higher incidence of CIN (40%) compared to those with clearance ≥60 ml/min (13%).
  • Independent predictors of CIN included age >75 years, anterior infarction, time-to-reperfusion >6 hours, contrast volume >300 ml, and intra-aortic balloon use. Patients with CIN experienced longer hospital stays (13 vs. 8 days) and a markedly higher mortality rate (31% vs. 0.6%).

Conclusions:

  • CIN is a frequent complication after primary PCI for AMI, even in patients with normal renal function.
  • CIN is associated with increased in-hospital complications and significantly higher mortality.
  • Preventive strategies are crucial, especially for high-risk patient populations undergoing primary PCI.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...